Is VOLITIONRX LTD (VNRX) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 21.7% / 30% | 12.2% / 30% | 0.4% / 30% | 0.81% / 5% | ✓ HALAL |
| DJIM | 21.7% / 33% | 12.2% / 33% | 0.4% / 33% | 0.81% / 5% | ✓ HALAL |
| MSCI | 61.9% / 33% | 34.7% / 33% | 1.2% / 33% | 0.81% / 5% | ✗ NOT HALAL |
| S&P | 21.7% / 33% | 12.2% / 33% | 0.4% / 33% | 0.81% / 5% | ✓ HALAL |
| FTSE | 61.9% / 33% | 34.7% / 33% | 1.2% / 50% | 0.81% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 100.0% | |
| Operating Margin | -813.2% | |
| Net Margin | 0.0% | |
| Return on Assets (ROA) | -148.3% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$26M |
| Free Cash Flow | -$26M |
| Total Debt | $6M |
| Current Ratio | 0.1 |
| Total Assets | $9M |
Price & Trading
| Last Close | $0.19 |
| 50-Day MA | $0.23 |
| 200-Day MA | $0.45 |
| Avg Volume | 8.4M |
| Beta | 1.4 |
|
52-Week Range
$0.17
| |
About VOLITIONRX LTD (VNRX)
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is based in Henderson, Nevada.
Purification Calculator
As a halal stock with 0.81% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is VOLITIONRX LTD (VNRX) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), VOLITIONRX LTD is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is VOLITIONRX LTD's debt ratio?
VOLITIONRX LTD's debt ratio is 21.7% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 61.9%.
Does VOLITIONRX LTD require dividend purification?
Yes, VOLITIONRX LTD has an impermissible income ratio of 0.81%, which means 0.81% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are VOLITIONRX LTD's key financial metrics?
VOLITIONRX LTD has a market capitalization of $27M, and revenue of $1M.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.